Effect of Food on the Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mgA Randomized, Open-Label, Crossover, Single-Centre Study

被引：0

作者：

Mona Darwish

Fang Xie

机构：

[1] Cephalon,Department of Clinical Pharmacology

[2] Inc.,Biometrics Department

[3] Cephalon,undefined

[4] Inc.,undefined

来源：

Clinical Drug Investigation | 2009年 / 29卷

关键词：

Oxybutynin; Food Effect; Tizanidine; Study Drug Administration; Aphthous Stomatitis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Background and objective: Food can alter the bioavailability of the controlled-release formulations of many different drugs. This study assessed the effect of food on the pharmacokinetics of once-daily cyclobenzaprine extended-release (CER) in healthy adult subjects.

引用

页码：145 / 152

页数：7

共 50 条

[1] Effect of Food on the Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mg A Randomized, Open-Label, Crossover, Single-Centre Study
Darwish, Mona
Xie, Fang
CLINICAL DRUG INVESTIGATION, 2009, 29 (03) : 145 - 152
[2] Comparison of the Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mg and Cyclobenzaprine Immediate-Release 10 mg Three Times Daily in the Elderly A Randomized, Open-Label, Crossover Study
Darwish, Mona
Xie, Fang
DRUGS & AGING, 2009, 26 (02) : 95 - 101
[3] Comparison of the Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mg and Cyclobenzaprine Immediate-Release 10 mg Three Times Daily in the ElderlyA Randomized, Open-Label, Crossover Study
Mona Darwish
Fang Xie
Drugs & Aging, 2009, 26 : 95 - 101
[4] Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended Release 30 mg versus Cyclobenzaprine Immediate Release 10 mg Three Times Daily in Healthy Young AdultsA Randomized, Open-Label, Two-Period Crossover, Single-Centre Study
Mona Darwish
Edward T. Hellriegel
Fang Xie
Clinical Drug Investigation, 2008, 28 : 793 - 801
[5] Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended Release 30 mg versus Cyclobenzaprine Immediate Release 10 mg Three Times Daily in Healthy Young Adults A Randomized, Open-Label, Two-Period Crossover, Single-Centre Study
Darwish, Mona
Hellriegel, Edward T.
Xie, Fang
CLINICAL DRUG INVESTIGATION, 2008, 28 (12) : 793 - 801
[6] Bioavailability of once-daily amantadine extended-release tablets in healthy adult volunteers: Results from a randomized, crossover, open-label study
Kumar, Sudershan
Srivastava, Abhishek
Devkare, Prashant
Bedi, Simrata
Khuroo, Arshad
Singh, Romi
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
[7] A Randomized Study of the Effects of Food on the Pharmacokinetics of Once-Daily Extended-Release Hydromorphone in Healthy Volunteers
Moore, Kenneth Todd
St-Fleur, Dominique
Marricco, Nadia Cardillo
Ariyawansa, Jay
Page, Veronique
Natarajan, Jayalakshmi
Morelli, Gaetano
Richarz, Ute
JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (11): : 1571 - 1579
[8] Pharmacokinetics of a New Once-Daily Controlled-Release Formulation of Aceclofenac in Korean Healthy Subjects Compared with Immediate-Release Aceclofenac and the Effect of Food A Randomized, Open-Label, Three-Period, Crossover, Single-Centre Study
Bae, Soo Kyung
Kim, Soo-Hwan
Lee, Hae Won
Seong, Sook Jin
Shin, Su-Yeon
Lee, Sang Hun
Lim, Mi-Sun
Yoon, Young-Ran
Lee, Hye Jung
CLINICAL DRUG INVESTIGATION, 2012, 32 (02) : 111 - 119
[9] Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies
deVries, Tina
Dentiste, Angela
Handiwala, Lata
Jacobs, David
NEUROLOGY AND THERAPY, 2019, 8 (02) : 449 - 460
[10] Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies
Tina deVries
Angela Dentiste
Lata Handiwala
David Jacobs
Neurology and Therapy, 2019, 8 : 449 - 460

← 1 2 3 4 5 →